Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia
- Author
- DORE, Gregory J1 ; YUEMING LI1 ; MCDONALD, Ann1 ; REE, Hugo2 ; KALDO, John M1
[1] National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Canada
[2] AIDS Medical Unit, The Prince Charles Hospital and Health Services, Brisbane, Australia
National HIV Suveillance Committee - Source
Journal of acquired immune deficiency syndromes (1999). 2002, Vol 29, Num 4, pp 388-395 ; ref : 36 ref
- ISSN
- 1525-4135
- Scientific domain
- Immunology, immunopathology, allergology; Virology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiviral Diagnostic Hodgkin maladie Homme Lymphocyte Lymphome non hodgkinien Modèle Pneumocystis carinii Pneumonie Pronostic SIDA Spécificité Traitement Tuberculose Virus immunodéficience humaine Antigène CD4 Protocole HAART Australie Appareil respiratoire pathologie Bactériose Fungi Imperfecti Fungi Hémopathie maligne Immunodéficit Immunopathologie Infection Lentivirus Lymphoprolifératif syndrome Mycobactériose Poumon pathologie Retroviridae Thallophyta Virose Virus Océanie
- Keyword (en)
- Antiviral Diagnosis Hodgkin disease Human Lymphocyte Non Hodgkin lymphoma Models Pneumocystis carinii Pneumonia Prognosis AIDS Specificity Treatment Tuberculosis Human immunodeficiency virus Australia Respiratory disease Bacteriosis Fungi Imperfecti Fungi Malignant hemopathy Immune deficiency Immunopathology Infection Lentivirus Lymphoproliferative syndrome Mycobacterial infection Lung disease Retroviridae Thallophyta Viral disease Virus Oceania
- Keyword (es)
- Antiviral Diagnóstico Hodgkin enfermedad Hombre Linfocito Linfoma no Hodgkin Modelo Pneumocystis carinii Neumonía Pronóstico SIDA Especificidad Tratamiento Tuberculosis Human immunodeficiency virus Australia Aparato respiratorio patología Bacteriosis Fungi Imperfecti Fungi Hemopatía maligna Inmunodeficiencia Inmunopatología Infección Lentivirus Linfoproliferativo síndrome Micobacteriosis Pulmón patología Retroviridae Thallophyta Virosis Virus Oceania
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04E Carcinogenesis, carcinogens and anticarcinogens / 002B04E04 Viruses
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13576978
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/00126334-200204010-00010 
https://dx.doi.org/10.1097/00126334-200204010-00010
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00126334-200204010-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"388\";s:8:\"\u0000*\u0000epage\";s:3:\"395\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"DORE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Gregory J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"YUEMING LI\";i:1;s:13:\"MCDONALD, Ann\";i:2;s:9:\"REE, Hugo\";i:3;s:13:\"KALDO, John M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00126334-200204010-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"388\";s:8:\"\u0000*\u0000epage\";s:3:\"395\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"DORE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Gregory J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"YUEMING LI\";i:1;s:13:\"MCDONALD, Ann\";i:2;s:9:\"REE, Hugo\";i:3;s:13:\"KALDO, John M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00126334-200204010-00010\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00126334-200204010-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"388\";s:8:\"\u0000*\u0000epage\";s:3:\"395\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"DORE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Gregory J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"YUEMING LI\";i:1;s:13:\"MCDONALD, Ann\";i:2;s:9:\"REE, Hugo\";i:3;s:13:\"KALDO, John M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00126334-200204010-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"388\";s:8:\"\u0000*\u0000epage\";s:3:\"395\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"DORE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Gregory J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"YUEMING LI\";i:1;s:13:\"MCDONALD, Ann\";i:2;s:9:\"REE, Hugo\";i:3;s:13:\"KALDO, John M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
